Don't have an account?
Click above to learn more about our broad molecular imaging agent portfolio as well as access Important Safety Information & Full Prescribing Information for each product.
5M
patients impacted annually worldwide1
3 CGMP
certified molecular imaging production facilities globally
10,000+
clinical trial doses worldwide1
Products
- Cerianna
- Datscan
- Vizamyl
- Flyrcado
- Myoview
- Adreview
- Datquant
- Ceretec
Radiopharmaceutical Locator Tool
Locate imaging centers and contract manufacturing organizations (CMOs) where molecular imaging agents from GE HealthCare may be available.
To ensure you and your patients have access, simply enter your zip code and select a product to find where it is available near you
Molecular imaging in precision medicine
Our focus is on precision medicine – an innovative approach to tailoring disease management with the most effective treatment pathway. We bring clinically relevant applications to our healthcare professionals and work to improve access to nuclear medicine – transforming patient outcomes.
Pharma services
Accelerating diagnostic and therapeutic research to improve patient lives
Our Pharma Services offering provides access to GE HealthCare's tracer portfolio, which can be tailored to the needs of your clinical study. Our biomarkers enable you to select the right patients, and monitor patient progression long-term, so you can test your hypothesis more accurately.
We also have an established global network of suppliers, and a dedicated in-house team, supporting you in keeping your project on track. Our many years of experience in managed dose supply mean that you can plan and schedule patients with confidence.
We also have an established global network of suppliers, and a dedicated in-house team, supporting you in keeping your project on track. Our many years of experience in managed dose supply mean that you can plan and schedule patients with confidence.
New tracers
We are committed to bringing innovative solutions to patients.
We welcome the opportunity to collaborate with leading academic institutions, biotech and pharmaceutical companies to innovate in molecular imaging across disease areas to enable clinicians to better diagnose, treat and monitor complex diseases and to advance care for patients with unmet needs. For information on business development or partnering opportunities, please contact our Pharmaceutical Diagnostics Licensing department.
Product Certificates
Access release certificates of conformity and analysis for our molecular imaging agent products on our Product Certification page.
References
- GE HealthCare data on file.
JB07962US June 2025